The Research and Development Team at Argenx is responsible for discovering, designing, and developing innovative antibody therapeutics. The team comprises scientists and researchers who conduct cutting-edge research, ensure compliance with drug substance development, monitor safety and efficacy, and manage the quality of development products. Their work is pivotal in advancing the company’s pipeline of treatments for cancer and autoimmune diseases, ultimately aiming to meet the needs of patients globally.
Alexandre Brossard
CMC Drug Substance Principal S...
Arpad Simon
Vice President, Head Of Global...
Conor mc Guire
Principal Scientist
Daniel Kavanagh
Senior Scientist, Asia Pacific...
Heleen Dewitte
Senior Scientist Discovery
Julie Jacobs
Principal Scientist
Kirsten van Hecke
Head Development Product Quali...
Laura Bracke
Associate Scientist
Lise Hennebel
Senior Research Associate
Nicolas Grancher
Senior Scientist CMC Complianc...
Rute Tavares
Study Monitor / Senior Researc...
Sofie Priem
Principal Scientist Nonclinica...
Sofie Voet
Senior Scientist R&d